Remote Prescribing and CQC: A Governance Checklist for ADHD and Telehealth Providers
Remote assessment and prescribing sit at the centre of how ADHD and telehealth services are judged as safe. Here is a practical governance checklist to test your service against before an inspector does.
· Barker & Scott
For ADHD and telehealth providers, the prescribing pathway is the service. Assessment, titration, monitoring and repeat supply all happen at a distance, and much of the medication involved is controlled. When an inspector asks whether your service is safe, this is where they will look first.
The good news is that the expectations are not mysterious. They flow from Regulation 12 (safe care and treatment), from the GMC's guidance on prescribing and managing medicines — which applies equally to remote consultations — and from the controlled drugs regime. What inspectors want to see is that you have thought each risk through, written down how you manage it, and can show it working in practice.
1. Identity and eligibility, every time
Remote services carry a risk that face-to-face care mostly doesn't: you may not be treating who you think you are treating.
- A documented process for verifying identity and age before assessment and before any prescription is issued.
- Clear criteria for who the service is not suitable for, and what happens when a patient falls outside them.
- Evidence that clinicians follow the process — not just that it exists.
2. Access to relevant history
Prescribing safely at a distance depends on knowing what else is going on. Your policy should state what information you need before prescribing (GP records, current medicines, relevant physical health checks), how you obtain it with consent, and what the clinician does if it isn't available. "We ask the patient" is rarely enough on its own for a controlled drug.
3. Controlled drugs handled as controlled drugs
Stimulant medicines used in ADHD — methylphenidate, lisdexamfetamine and dexamfetamine — are Schedule 2 controlled drugs. Your governance should reflect that:
- Prescription limits and intervals that are set, recorded and followed.
- A named accountable officer arrangement where required, and a clear route for reporting concerns.
- Audit of prescribing patterns, including early requests and lost-prescription claims.
4. Titration and monitoring that actually happens
Titration is where remote models most often drift. Inspectors will look for scheduled reviews that took place, physical observations (blood pressure, pulse, weight) recorded at the intervals your own protocol sets, and a documented response when a patient misses a review. If your protocol says four weeks and your records show twelve, the protocol becomes evidence against you.
5. Shared care, with clear ownership
Many ADHD patients move to shared care with their GP. The risk sits in the handover. Be clear who is responsible for prescribing and monitoring at each stage, what the GP has agreed to, and what happens when a GP declines. Patients should never be left without a prescriber because the paperwork stalled.
6. Safeguarding and crisis pathways
A remote service still needs to know what to do when a patient discloses risk mid-consultation. Your safeguarding policy should cover remote-specific scenarios — including how you contact local services for a patient hundreds of miles away — and staff should be able to describe it without reaching for the document.
7. Oversight from the top
Under the well-led key question, leaders are expected to know how the prescribing pathway is performing. That means regular clinical audit, a record of incidents and what changed as a result, and board or leadership minutes that show these topics are discussed rather than filed.
Turning the checklist into evidence
None of this requires a new framework. It requires policies that describe what you really do, records that prove it, and an audit cycle that catches drift before an inspector does. With the CQC moving towards sector-specific frameworks and returning key lines of enquiry, this kind of clear, practical evidence will carry straight across.
If your prescribing and medicines governance documents need tightening, our telehealth and ADHD policy templates are built for exactly these pathways → barker-scott.co.uk/policies